Table 1:
Demographics of the entire cohort (n=1279)
| Characteristic | N (%) |
|---|---|
| Age | |
| Min-Max (years) | 15–95 |
| Mean (years ±SD) | 60.7 ±13.6 |
| Gender | |
| Male | 685 (53.6%) |
| Female | 594 (46.4%) |
| Race | |
| White | 855 (66.8%) |
| Black | 367 (28.7%) |
| Asian | 37 (2.9%) |
| Other | 20 (1.6%) |
| BMI | |
| < 18.5 | 63 (4.9%) |
| 18.5 – 24.9 | 394 (30.8%) |
| 25 – 29.9 | 371 (29.0%) |
| >30 | 309 (24.2%) |
| Unknown | 142 (11.1%) |
| Stage | |
| Stage 1 | 255 (19.9%) |
| Stage 2 | 330 (25.8%) |
| Stage 3 | 386 (30.2%) |
| Stage 4 | 308 (24.1%) |
| Site | |
| Colon | 905 (70.8%) |
| Rectum | 374 (29.2%) |
| Emergent Surgery | |
| No | 1269 (99.2) |
| Yes | 10 (0.8) |
| Anastomotic Leak | |
| No | 1213 (94.8%) |
| Yes | 66 (5.2%) |
| SSI | |
| No | 1092 (85.4%) |
| Yes | 187 (14.6%) |
| Bowel Prep | |
| No | 949 (74.2%) |
| Yes | 330 (25.8%) |
| Radiation | |
| No | 1024 (80.1%) |
| Yes | 255 (19.9%) |
| Chemotherapy | |
| No | 818 (64.0%) |
| Yes | 461 (36.0%) |
| Blood Transfusion | |
| No | 1137 (88.9%) |
| Yes | 142 (11.1%) |
| Years of Follow Up | |
| 1 year | 273 (21.3%) |
| 2 years | 224 (17.5%) |
| 3 years | 213 (16.7%) |
| 4 years | 147 (11.5%) |
| 5 years | 122 (9.5%) |
| ≥6 years | 200 (23.5%) |
SD = standard deviation
BMI = body mass index
SSI = surgical site infection